Repair of mitomycin C mono- and interstrand cross-linked DNA adducts by UvrABC: a new model by Weng, Mao-wen et al.
Repair of mitomycin C mono- and interstrand
cross-linked DNA adducts by UvrABC:
a new model
Mao-wen Weng
1, Yi Zheng
1, Vijay P. Jasti
2, Elise Champeil
3, Maria Tomasz
4,
Yinsheng Wang
5, Ashis K. Basu
2,* and Moon-shong Tang
1,*
1Department of Environmental Medicine, Pathology, and Medicine, New York University School of Medicine,
Tuxedo, New York 10987,
2Department of Chemistry, University of Connecticut, Storrs, Connecticut 06269,
3Department of Science, John Jay College, City University of New York, New York 10019,
4Department of
Chemistry, Hunter College, City University of New York, New York, New York 10021 and
5Department of
Chemistry, University of California, Riverside, CA 92521, USA
Received March 17, 2010; Revised May 5, 2010; Accepted June 8, 2010
ABSTRACT
Mitomycin C induces both MC-mono-dG and
cross-linked dG-adducts in vivo. Interstrand
cross-linked (ICL) dG-MC-dG-DNA adducts can
prevent strand separation. In Escherichia coli cells,
UvrABC repairs ICL lesions that cause DNA bending.
The mechanisms and consequences of NER of ICL
dG-MC-dG lesions that do not induce DNA bending
remain unclear. Using DNA fragments containing a
MC-mono-dG or an ICL dG-MC-dG adduct, we
found (i) UvrABC incises only at the strand contain-
ing MC-mono-dG adducts; (ii) UvrABC makes three
types of incisions on an ICL dG-MC-dG adduct: type
1, a single 50 incision on 1 strand and a 30 incision
on the other; type 2, dual incisions on 1 strand and
a single incision on the other; and type 3, dual
incisions on both strands; and (iii) the cutting
kinetics of type 3 is significantly faster than type 1
and type 2, and all of 3 types of cutting result in
producing DSB. We found that UvrA, UvrA+UvrB
and UvrA+UvrB+UvrC bind to MC-modified DNA
specifically, and we did not detect any UvrB- and
UvrB+UvrC–DNA complexes. Our findings chal-
lenge the current UvrABC incision model. We
propose that DSBs resulted from NER of ICL
dG-MC-dG adducts contribute to MC antitumor
activity and mutations.
INTRODUCTION
Mitomycin C (MC) is a potent antitumor drug. Although
this drug was discovered decades ago, it is still being
actively used clinically, in combination with other
antitumor drugs, for the treatment of advanced cancers
(1–4). Upon entering cells MC is chemically reduced to a
form that can react with deoxyguanosine (dG) residues
in DNA to form a MC-mono-dG adduct. Mitomycin C
can further form an intrastrand biadduct at –GG- sites
and an interstrand cross-linked (ICL) dG-MC-dG lesion
at a –CG- site (5). If not repaired, these DNA adducts,
particularly ICL lesions, can block transcription and
DNA replication and cause cell death (6). The antitumor
activity of MC is generally believed to be derived from
these interactions with DNA (7,8).
Both eukaryotes and prokaryotes have the capacity to
repair MC-DNA adducts. The MC-mono-dG adducts are
repaired by the nucleotide excision repair (NER) mecha-
nism, which is similar to what occurs with other bulky
DNA adducts, such as benzo(a)pyrene diol epoxide-dG
adducts and cyclobutane pyrimidine dimers (CPD) photo-
products (9,10). We previously have shown that UvrABC
nuclease, the NER enzyme complex in Escherichia coli
cells, makes an incision 7–8nt 50 to and 3–4nt 30 to an
MC-mono-dG adduct (10). It is likely that the intrastrand
biadduct at –GG- sites is repaired in the same fashion as
CPD and MC-mono-dG adducts, but the repair of ICL
dG-MC-dG lesion is less clear. The current understanding
of ICL lesions is derived primarily from results of studying
*To whom correspondence should be addressed. Tel: +1 845 731 3585; Fax: +1 845 351 2385; Email: moon-shong.tang@nyumc.org
Correspondence may also be addressed to Ashis K. Basu. Tel: +1 860 486 3965; Email: ashis.basu@uconn.edu
6976–6984 Nucleic Acids Research, 2010, Vol. 38, No. 20 Published online 6 July 2010
doi:10.1093/nar/gkq576
 The Author(s) 2010. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.UvrABC nuclease incision on ICL thymidine-psoralen-
thymidine (dT-psoralen-dT) lesions (11,12). However,
results from studies on UvrABC recognition and repair
of ICL dT-psoralen-dT lesions are inconsistent; while
van Houten et al. (11,12) have shown that the UvrABC
nuclease makes dual incisions only at the DNA strand
with the furan side of ICL dT-psoralen-dT lesion,
Ramaswamy and Yeung (13) have demonstrated that
the UvrABC nuclease can make incisions on both
strands of this type of lesion. Sladek et al. (14,15) have
demonstrated that the ICL dT-psoralen-dT adduct in a
circular double-stranded DNA can be removed and
repaired by the concerted actions of UvrABC incision,
recA-mediated DNA strand invasion and DNA polymer-
ase I-mediated repair synthesis.
An ICL dG-MC-dG has two distinct structural differ-
ences from an ICL dT-psoralen-dT: 1, dG residues are
cross-linked instead of dT residues, and 2, the MC
moiety sticks out of the minor groove and does not
induce DNA bending (16), while the psoralen moiety is
hidden within the base stacks and induces a 46.5
o kink in
the DNA helix (17). Similar to the ICL dG-MC-dG
adduct, it has been shown that an MC-mono-dG adduct
does not induce DNA bending (16). If an ICL dG-MC-dG
adduct does not cause DNA bending then what are the
signals for UvrABC to recognize this adduct as a DNA
lesion? Since the 2 dGs in both DNA strands in this lesion
are covalently bonded with the same MC molecule, how
does UvrABC incise an ICL dG-MC-dG adduct?
To address these questions, we determined the recogni-
tion and incision of two types of MC–DNA lesions by
UvrABC nuclease, using substrates of 61-bp DNA frag-
ments containing either a site-speciﬁc ICL dG-MC-dG or
MC-mono-dG adduct at the same site.
MATERIALS AND METHODS
Materials
The restriction enzymes SmaI and SnaBI were obtained
from Roche. T4 polynucleotide kinase was obtained
from DuPont New England Biolabs. Acrylamide, bis-
acrylamide, APS and yeast tRNA were purchased from
the Sigma Chemical Company. The g-
32P-ATP was
purchased from Perkin Elmer.
Preparation of 61-mer containing a site-speciﬁc
MC-mono-dG or an ICL dG-MC-dG adduct
15-mer containing a MC-mono-adduct. The 15-mer oligo-
nucleotide [d(TCTATACGTAGAATT)] was annealed
to a 9-mer [d(TAC
5-MeGTATAG)] and then reacted
with MC (4mmol/ml) using a previously described
method (18,19). The adducted duplexes were separated
by high-performance liquid chromatography (HPLC).
61-mer duplex containing a MC-mono-dG. The 61-mer
containing a site-speciﬁc MC-mono-dG adduct was con-
structed by ligating the MC-mono-adducted 15-mer, the
phosphorylated 23-mer, [d(CCCATAGGAGAATTCCT
ACCCTA)], unphosphorylated 23-mer, [d(GCTCGGTA
CCCGGGGATATCCTC)] and a 39-mer scaffold
oligonucleotide, [d(TTCTCCTATGGGAATTCTACGT
ATAGAGAGGATATCCCC)]. The ligated 61-mer was
isolated by gel electrophoresis and stored at  20 C.
MC-cross-linked 61-mer duplex. The 61-bp fragments
containing a site-speciﬁc ICL dG-MC-dG adduct were
generated by hybridizing the MC-mono-adduct–con-
taining 61-mer with its complementary 61-mer, and the
duplexes underwent further MC cross-linking using previ-
ously described reaction conditions (18,19). The N
2-
dG-MC-N
2-dG interstrand cross-link–containing 61-mer
duplex was puriﬁed by PAGE.
Preparation of
32P-labeled DNA fragments
The single-stranded (SS) 61-mer fragment containing an
MC-mono-dG adduct or its complementary SS 61-mer
was dissolved in 1 TE buffer (10mM Tris–HCl, pH
8.0, 1mM EDTA), 50-end labeled with g-
32P-ATP by T4
polynucleotide kinase (New England, BioLab), hybridized
to each other, and then separated in a nondenaturing 8%
polyacrylamide gel. The DS 61-bp fragments containing a
site-speciﬁc ICL dG-MC-dG were 50-end-labeled with
g-
32P-ATP by T4 polynucleotide kinase at both ends; the
DNA fragments were then digested with SmaI to generate
single 50-end
32P-labeled fragments.
UvrABC nuclease reactions
The UvrA, UvrB and UvrC proteins were puriﬁed as pre-
viously described (9). An aliquot of the
32P-labeled 61-bp
DNA fragments (0.6–2.0nM) was reacted with the UvrA,
UvrB and UvrC proteins (15nM each) in UvrABC
reaction buffer (50mM Tris–HCI, pH 7.5, 10mM
MgC12, 100mM KC1, 1mM ATP and 1mM DTT) at
37 C for different time periods.
Kinetics of UvrABC incision
The
32P-labeled DS DNA fragments containing a site-
speciﬁc MC adduct were pre-incubated with 15nM
UvrA and 15nM UvrB at 37 C in UvrABC reaction
buffer and the reaction was then started with the
addition of UvrC (15nM). The UvrABC reaction
mixtures were sampled at different time intervals and the
resultant DNAs were puriﬁed and separated in a 12%
polyacrylamide denaturing or non-denaturing gel. The
DS DNA markers (15, 30 and 46bp) with and without
an ICL dG-MC-dG lesion were generated by digestion
of the 50-end
32P-labeled 61-bp DNA fragments with
EcoRV and SnaBI restriction enzymes. The intensity of
the electrophoresis-separated bands was determined by
scanning with a Packard Cyclone
TM Storage Phosphor
System.
Detection of Uvr–DNA binding by gel mobility
shift assay
The 61-bp DNA fragments with a site-speciﬁc
MC-mono-dG or an ICL dG-MC-dG adduct were
32P
50-end-labeled and reacted with Uvr proteins under three
different conditions: (i) UvrA (15nM) only for 5min; (ii)
UvrA and UvrB (15nM each) for 5min; and (iii) the same
as in (ii) and then UvrC (15nM) was added. The DNA
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were carried out in the same UvrABC reaction buffer used
in the UvrABC incision reactions except bovine serum
albumin (BSA) (0.1mg/ml) was added to maintain the
stability of the Uvr–DNA complexes. The presence
of BSA did not affect the UvrABC incision activity. The
mixtures were incubated at 37 C for 20min and then
separated in a 4.5% polyacrylamide gel containing
10mM MgCl2 and 2mM ATP by electrophoresis in
0.5 TBE buffer the same as described by Delagoutte
et al. (20) except that the electrophoresis was conducted
at 2 C. After 1h of electrophoresis, the gel was exposed to
phosphor screen (30min) and then rerun for 1 more hour
under the same conditions. The DNA and protein–DNA
complexes were analyzed using a Packard CycloneTM
Starage Phosphor System. All gel retardation experiments
were repeated at least three times.
Determination of the composition of Uvr-MC–modiﬁed
DNA complexes
The Uvr–DNA complex bands separated by gel electro-
phoresis were cut, smashed and heated at 95 C for 5min
in the presence of 2% SDS to dissociate the Uvr proteins
from the complexes. The resultant mixtures were then
electrophoresed in an 8% SDS PAGE and stained with
silver stain.
RESULTS
Construction of 61-bp DNA fragments containing a
site-speciﬁc MC-mono-adduct or ICL dG-MC-dG adduct
In order to obtain deﬁnitive UvrABC–DNA adduct inter-
actions 61-bp DNA fragments containing a site-speciﬁc
MC-mono-dG adduct (substrate 1) or an ICL dG-MC-
dG adduct were constructed (substrate 2) (Figure 1B).
The presence of an MC-mono-dG adduct and ICL-dG-
MC-dG adduct in these DNA fragments was conﬁrmed
by enzymatic digestion followed by HPLC separation
and by LC-ESI-MS analyses (18) (Supplements 1–3).
The interstrand crosslink was further characterized
by denatured electrophoresis. Results in Figure 1C show
that the denatured 61-bp fragments that contain an ICL
dG-MC-dG migrate signiﬁcantly slower than the
denatured 61-bp fragments that contain an MC-mono-
dG, indicating that the two DNA strands in the former
are covalently linked.
Recognition and incision of MC-mono-dG and ICL
dG-MC-dG adducts by UvrABC
Previously, using DNA fragments modiﬁed with MC, we
have shown that the NER enzyme complex UvrABC
nuclease is able to recognize MC-mono-dG adducts and
make dual incisions 7–8nt 50 to and 4–5nt 30 to the adduct
(10,21). Since dG residues in both strands of these DNA
fragments were modiﬁed with MC, our previous results
Figure 1. (A) Chemical structures of MC, MC-mono-dG, and ICL dG-MC-dG DNA adducts. (B) The DNA sequence of the 61-bp DNA fragment
containing a site-speciﬁc MC-mono-dG (substrate 1) or an ICL dG-MC-dG adduct (substrate 2). G* represents MC-modiﬁed deoxyguanosine.
Restriction enzyme SmaI site is indicated. (C) Substrate 1, substrate 2 and control 61-bp DNA fragments were 50-end
32P labeled, denatured and then
separated by electrophoresis in a denaturing gel.
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may induce UvrABC incision on the DNA strand
opposite to the MC-mono-dG adduct. To test this possi-
bility the 61-bp DNA fragments containing a site-speciﬁc
MC-mono-dG adduct were 50-end-
32P labeled at either the
MC-adduct strands (substrate 1) or the non-adducted
strands as shown in Figure 1B, and then reacted with
UvrABC nuclease for different time periods. The results
in Figure 2A show that UvrABC incises the
MC-mono-dG-containing strands as a function of incuba-
tion time and incisions mainly occur at 7nt with minor
incisions 8 and 9nt, 50 to the MC-dG; these results are
consistent with previous ﬁndings (10,21). In contrast,
UvrABC does not incise the complementary strands that
do not contain an MC-mono-dG adduct even after a
60-min incubation period (Figure 2B).
In order to determine whether the NER mechanism
can recognize and repair ICL dG-MC-dG adducts,
the 61-bp DNA fragments that contain a site-speciﬁc
ICL dG-MC-dG (substrate 2) were
32P-labeled on both
50 ends, digested with SmaI to generate a single 50-end
32P-labeled fragment and then incubated with UvrABC
nucleases for different time periods. The results in
Figure 2C show that these reactions generate a major
32P band that corresponds to the incision at 9nt and
also to minor incisions 8 and 10nt 50 to the lesion, and
the incision is a function of the incubation time. These
results indicate that UvrABC is able to recognize the
ICL dG-MC-dG adduct and makes incisions mainly 9nt
50 to this lesion. To determine the cutting efﬁciency
of UvrABC toward these MC-mono-dG and ICL
dG-MC-dG adducts, we determined the kinetics of
UvrABC incision on these two types of lesions. Results
in Figure 2D show that UvrABC incises these two types of
adducts with similar pseudo-ﬁrst order kinetics and rate
constants. Although the initial slopes of the two curves are
different, we interpret these results as indicating that the
two types of adducts are recognized and incised by the
UvrABC nuclease with similar efﬁciencies.
Figure 2. Kinetics of UvrABC incision of MC-mono-dG and ICL dG-MC-dG adducts. In (A) the MC-mono-dG–containing strand of substrate 1
was 50-
32P-end labeled. In (B) the MC-mono-dG–containing strand of substrate 1, the non-modiﬁed strand (Comp) of substrate 1, and control 61-bp
fragments were 50-
32P-single-end labeled. In (C) substrate 2 was
32P-labeled at the 50 end on both strands and digested with SmaI to generate single
50-end-
32P-labeled DNA fragments. The DNA fragments were incubated with UvrABC for different time periods (A and C), or for 60min (B), and
the resultant DNAs were separated by electrophoresis in a 12% polyacrylamide denaturing gel. (A–C) represent typical autoradiographs, and (D)
represents the quantitations. The band intensities at different times (It) were normalized to the intensity at 32min (I32), which encompasses 90% of
total activity. The inset shows a semilogarithmic plot; the slopes yield two apparent ﬁrst-order rate constants, Kobs,ABC, mono=0.111min
 1 and
Kobs,ABC, ICL=0.169min
 1. Symbols: AG and TC represent Maxam and Gilbert sequencing reaction products (42); G*, MC-modiﬁed guanine; the
arrows indicate the UvrABC incision bands; MC-mono-dG (ﬁlled triangle with dashed line); and ICL dG-MC-dG adducts (open circle with
continous line).
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in double-stranded DNA break
The results from LC-MS/MS analysis (Supplement 3) and
gel electrophoresis (Figure 1C) indicate at the ICL
dG-MC-dG lesion the two dGs at the two DNA strands
are indeed covalently bonded by the same MC molecule. If
UvrABC makes a dual incision at 50 and 30 of these two
MC-bonded dG’s, similar to the dual incision seen with
the MC-mono-dG adduct, then this type of incision
should produce a DSB. To test this possibility, the 61-bp
DNA fragments containing a site-speciﬁc ICL
dG-MC-dG or a MC-mono-dG were labeled with
32Pa t
both 50 ends, incubated with UvrABC nuclease for differ-
ent times, and the resultant DNAs were separated by elec-
trophoresis in a non-denaturing gel. The results in Figure
3A show that while UvrABC incision of MC-mono-dG
fragments does not produce any shorter DNA fragments
than the original 61-bp DNA fragments, UvrABC incision
of ICL dG-MC-dG fragments produces three major DNA
fragments I (42bp), II (40bp) and III (22–24bp). Results
in Figure 3B show that the formation of these three bands
is a function of incubation time and no intermediate
products were produced besides the end products
observed after very short as well as after very long
periods of incubation. Kinetic analysis shows that the
rate constant of band III formation is signiﬁcantly larger
than Band I and Band II. These results indicate that once
the UvrABC–ICL dG-MC-dG complex is formed the
pattern of UvrABC incision is determined. To identify
the nature of these three bands, DNA in each was
isolated, denatured and separated by electrophoresis in a
12% denaturing gel. The results in Figure 4A show that
the size of band I is  73nt+ICL, band II is  46nt+ICL
and band III is 20–23nt. It should be noted that all three
bands contain a band with a size that corresponds to a
single-stranded 61-nt fragment. We believe this single-
stranded 61-nt fragment is a contaminant originating
from the double-stranded DNA construction. To
exclude the trivial possibility that the DNA isolation
process may generate different size of DNA fragments,
UvrABC incised ICL dG-MC-dG fragments were
denatured and separated by electrophoresis in a denatured
gel. Results in Figure 4B show the same four DNA frag-
ments (73nt+ICL, 61nt, 46nt+ICL and 20–23nt) were
observed indicating that these DNA fragments were
indeed the UvrABC incision products.
The pattern of UvrABC incision on of 61-bp DNA
fragments containing a site-speciﬁc ICL dG-MC-dG
adducts
Based on the results shown in Figures 2–4B, we con-
structed the possible patterns of UvrABC incision on the
double-end
32P-labeled 61-bp DNA fragments containing
a site-speciﬁc ICL dG-MC-dG (Figure 4C). It appears
that UvrABC makes three types of incisions on this type
of adduct: type 1, a single incision at 8–10nt 50 to the ICL
dG-MC-dG on 1 strand and 4nt 30 to the other strand;
type 2, dual incisions on 1 strand and a single incision 30 to
the ICL dG-MC-dG; and type 3, dual incisions at 8–10nt
50 to and 4–5nt 30 to the ICL dG-MC-dG on both strands.
The type 1 cut generates two
32P-labeled DNA duplexes: a
24-/27-nt and a 34-/39-nt, with the latter containing the
ICL dG-MC-dG adduct. The type 2 cut generates two
32P-labeled DNA duplexes: a 24-/27-nt and a 34-/39-nt,
and the latter contains the ICL dG-MC-dG adduct, just
as with type 1. However with the added incision site, a
single-strand break is generated, resulting in a 46-nt
fragment containing the adduct. The type 3 cut generates
one kind of
32P-labeled DNA duplex: 24-/27-nt. All three
types of incision result in generation of double-stranded
DNA break (DSB). Based on the band intensity shown
in Figure 3B and the models of cutting presented in
Figure 4C we calculated the kinetics and the distribution
of the three types of UvrABC cutting. The results indicate:
(i) the rate constant of type 3 cutting is signiﬁcantly higher
Figure 3. Double-stranded DNA break formation resulted from
UvrABC incision of an ICL dG-MC-dG adduct. (A)
32P-labeled sub-
strate 1, substrate 2 and control 61-bp DNA fragments were reacted
with UvrABC for 60min and then separated in a nondenaturing
polyacrylamide gel. (B) The kinetics of DSB formation resulted
from UvrABC incision of an ICL dG-MC-dG DNA adduct. The
50-end-
32P-labeled 61-bp DNA fragments containing a site-speciﬁc
ICL dG-MC-dG–DNA adduct were incubated with UvrABC nucleases
as described in Figure 2. At different time periods of incubation, the
resultant DNAs were separated in a nondenaturing polyacrylamide gel.
The double-stranded DNA fragments standards are shown in lane M.
(C) Quantitations. The band intensities at different times (It) shown in
(B) were normalized to the intensity at 32min (I32), which encompasses
90% of total activity. The data were plotted the same as in Figure 2.
6980 Nucleic Acids Research, 2010,Vol.38, No. 20than type 1 and type 2 cutting (Figure 4D), and (ii) type 1
and type 3 cuttings (40% each) are more frequent than
type 2 cutting (20%).
Binding of MC-mono-dG and ICL dG-MC-dG adducts
by Uvr proteins
Using a site-speciﬁc cholesterol-dG as a substrate it has
been found that the sequential steps of binding and
incision of the lesion by the three Uvr proteins are as
follows: (i) a dimerized UvrA binds to the lesion to form
a (UvrA)2–DNA lesion complex; (ii) the complex attracts
a UvrB, which binds to form a (UvrA)2(UvrB)–lesion
complex; (iii) UvrA is released from the complex and a
UvrC joins in to form a (UvrB)(UvrC)–lesion complex
and triggers dual incisions at both the 50 and 30 sides of
the DNA lesion (22–25). While this Uvr–DNA interaction
model can account for the dual UvrABC incision on a
MC-mono-dG adduct, it cannot account for the type 2
and type 3 UvrABC incisions on an ICL dG-MC-dG
adduct. The type 2 and type 3 UvrABC incisions on an
ICL dG-MC-dG adduct raise the possibility that UvrABC
may form a complex or complexes with this type of adduct
that is different from the ones that are formed with the
MC-mono-dG adduct. To test this possibility, we
determined the binding pattern of Uvr proteins UvrA,
UvrA+UvrB and UvrA+UvrB+UvrC with the 61-bp
DNA fragments containing a MC-mono-dG adduct or
an ICL dG-MC-dG under the incision reaction condi-
tions. The results in Figure 5A show that: (i) Uvr
proteins do not bind to undamaged control DNA frag-
ments signiﬁcantly; this result is distinctly different from
other reports that show a signiﬁcant amount of Uvr
binding to undamaged DNA fragments (26,27). (ii)
UvrA binds to MC-mono-dG, resulting in a single band,
which is indicative of the formation of a
(UvrA)2(MC-mono-dG) complex since it is well estab-
lished that UvrA dimerizes in UvrABC reaction buffer
(22–25,28). (iii) Addition of UvrB results in a different,
slower moving band, representing the formation of a
(UvrA)2(UvrB)(MC-mono-dG) complex. (iv) Addition
of UvrC protein results in the generation of a further
retarded band, indicating the formation of a
(UvrA)2(UvrB)(UvrC)(MC-mono-dG) complex.
Figure 4. Identiﬁcation of the products resulting from UvrABC
incision of the 61-bp DNA fragments containing an ICL
dG-MC-dG–DNA adduct. (A) The three major bands (I, II and III)
as shown in Figure 3 were extracted and separated by electrophoresis in
a 12% polyacrylamide denaturing gel as described in Figure 2. Note:
the DNA fragments in band I resulted in a band corresponding to size
of  73nt+ICL, the DNA fragments in band II resulted in a band
corresponding size of  46nt+ICL, and the DNA fragments in band
III resulted a band of size  22-nt bands. The size standards were
generated using the 61– bp DNA fragment containing an ICL
dG-MC-dG adduct cut with EcoRI or EcoRV. The 61-nt band
results from an unreacted 61-mer contamination during the strand con-
struction. AG and TC represent Maxam and Gilbert sequencing
reaction products (42). (B)
32P-labeled 61-bp DNA fragments contain-
ing an ICL dG-MC-dG DNA adduct were incubated with UvrABC for
32min and the resultant DNAs were separated by electrophoresis the
same as in (A). (C) The three possible types (1, 2 and 3) of UvrABC
incision on the double-stranded 61-bp fragments containing a
site-speciﬁc ICL dG-MC-dG DNA adduct that would result in
generating fragments of the following approximate sizes: 73nt+ICL,
46nt+ICL and 22nt. The arrows indicate the UvrABC cutting sites.
For clarity, only the major incision positions are shown. It should be
noted that type 1, 2 and 3 incisions resulted in producing DSB. (D) The
kinetics of the three types of UvrABC cutting on the ICL dG-MC-dG
lesion. The calculations were based on the band intensity shown in
Figure 3B and the cutting models presented in Figure 4C.
Nucleic Acids Research, 2010,Vol.38, No. 20 6981We found that all Uvr proteins bound to the 61-bp
DNA fragments containing an ICL dG-MC-dG adduct,
and all the resultant complexes moved more slowly than
the corresponding Uvr proteins bound to 61-bp fragments
containing a MC-mono-dG adduct (Figure 5A). The
mobility of the ICL dG-MC-dG 61-bp DNA fragments
bound to UvrA is signiﬁcantly slower than the mobility
of the corresponding MC-mono-dG DNA fragment
bound to UvrA; we interpret this to mean that two
dimerized UvrA proteins bind to the ICL dG-MC-dG
lesion [(UvrA)2-(UvrA)2-ICL dG-MC-dG] while only 1
dimerized UvrA protein binds to the MC-mono-dG
lesions [(UvrA)2-MC-mono-dG]. Addition of UvrB
slightly retarded mobility further, suggesting the forma-
tion of a (UvrA)2(UvrB)-(UvrA)2(UvrB)-ICL dG-MC-
dG complex. Addition of UvrC resulted in further
mobility retardation of the complex, and we interpret
this to being due to the formation of a (UvrA)2(UvrB)
(UvrC)-(UvrA)2(UvrB)(UvrC)-ICL dG-MC-dG complex.
To determine the composition of the Uvr-MC-
mono-dG and Uvr-ICL-dG-MC-dG complexes the
bands in Figure 5A were isolated and the Uvr proteins
in the bands were further separated by SDS-PAGE. The
results in Figure 5B and C show that adding UvrA,
UvrA+UvrB and UvrA+UvrB+UvrC to the MC-
modiﬁed DNA, the Uvr proteins remain binding at
damaged DNA. These results indicate that UvrABC inci-
sions of MC-mono-dG and ICL-dG-MC-dG adducts
require the interactions and presence of all three Uvr
proteins.
DISCUSSION
The results presented here are consistent with a model in
which UvrABC incision of an ICL dG-MC-dG leads to
DSB formation because UvrABC makes single and dual
incisions 50 and 30 of an ICL dG-MC-dG adduct on both
DNA strands. Our results indicate that a signiﬁcant
amount of UvrABC incisions of ICL dG-MC-dG result
in DSB. The underlying mechanisms of NER are
conserved from prokaryotic cells to human cells (29–31).
It has been found that the initial incision step of NER in
human cells is similar to NER in E. coli cells, except that
in human cells 28–32nt are excised, including the damaged
base(s) (31). If the NER mechanism in human cells for
ICL dG-MC-dG is similar to NER in E. coli cells, then
NER should produce DSB in human cells and NER of
MC-induced DNA damage therefore would contribute to
MC antitumor activity since an unrepaired DSB is a po-
tential lethal event.
Our results suggest that the action of the UvrABC
complex on the ICL dG-MC-dG substrate results in
excision of a 12–13-bp DNA fragment. In human cells,
we expect NER of ICL dG-MC-dG will result in the
excision of a 24–32-bp DNA segment. If this type of
DSB is repaired by the end-to-end joining mechanism
in situ then it would result in a small deletion. If the
DSB causes a chromosome translocation, it would also
result in a deletion in the translocated chromosome. In
either case, an ICL dG-MC-dG–induced, NER-mediated,
end-to-end joining event is mutagenic and this event
probably contributes to the secondary tumorigenesis that is
very often found in patients after long-term use of MC (32).
In contrast with our ﬁnding that UvrABC incision of
the ICL dG-MC-dG adduct results in DSB, using DNA
fragments containing a site-speciﬁc ICL dT-psoralen-dT
Figure 5. The binding pattern of Uvr proteins with
32P-labeled DS
61-bp DNA fragments with and without a site-speciﬁc MC-mono-dG
or an ICL dG-MC-dG adduct. In (A) the DNA fragments were
incubated with UvrA, UvrA+UvrB and UvrA+UvrB+UvrC for
20min and the resultant complexes were separated by electrophoresis
in a 4.5% non-denaturing polyacrylamide gel containing 50mM MgCl2
and 1mM ATP at 2 C in 0.5 TBE buffer for 2h (lanes 1–12). The
Uvr–DNA complexes are: (UvrA)2–DNA (lane 6); (UvrA)2-(UvrB)–
DNA (lane 7); (UvrA)2-(UvrB)-(UvrC)–DNA (lane 8); (UvrA)4–DNA
(lane 10); (UvrA)4-(UvrB)2–DNA (lane 11) and (UvrA)4-(UvrB)2-
(UvrC)2–DNA (lane 12). To determine the Uvr protein composition
in the Uvr–DNA complexes resulting from Uvr-bound DS 61-bp
DNA fragments containing a site-speciﬁc (B) MC-mono-dG or
(C) ICL dG-MC-dG adduct, bands isolated from Figure 5A were
denatured by heat (95 C in 2% SDS for 5min), separated in an 8%
SDS-PAGE, and stained with silver stain. The Uvr proteins added
to the DNA fragments that resulted in the different retarded bands
are shown on the top of the panel. In (B) lane 2 is from lane 6 of
Figure 5A; lane 3 is from lane 7 of Figure 5A; lane 4 is from lane 8 of
Figure 5A In (C) lane 6 is from lane 10 of Figure 5A; lane 7 is from
lane 11 of Figure 5A; lane 8 is from lane 12 of Figure 5A. Lanes 1 and
5 are the UvrA, UvrB and UvrC standards. Note: The complexes in
each band contain all the added Uvr protein (i.e. UvrA was found in
the MC-modiﬁed DNA added with UvrA; UvrA and UvrB were found
in MC-modiﬁed DNA added with these two proteins; and UvrA, UvrB
and UvrC were found in the MC-modiﬁed DNA added with these three
proteins).
6982 Nucleic Acids Research, 2010,Vol.38, No. 20lesion van Houten et al. (11,12) found that UvrABC
makes a dual incision only on the strand that interacts
with the furan moiety of psoralen and does not cause a
DSB. Moreover, while Pitte and Hearst (33) found that a
dT-psoralen-dT ICL causes a 46.5
o kink, Rink et al. (16)
found that both MC-mono-dG and ICL dG-MC-dG
lesions do not cause DNA bending. Given these contrast-
ing results, it is likely that the differing effects on DNA
secondary structure caused by these two different ICL
lesions determines the mode of UvrABC incision. While
our work was in progress Peng et al. (34) and Sczepanski
et al. (35) reported that UvrABC incision of ICL dT-dA
results in both single-stranded DNA breaks and DSBs.
Two distinct models of how UvrABC recognizes and
incises DNA damage have been proposed (22–25,28).
Works from Grossman’s laboratory (28) supported
the model that suggests dimerized UvrA form a
(UvrA)2UvrB complex that localizes and binds to the
DNA lesion; UvrC then joins the complex and triggers
dual incisions. On the other hand, works from Sancar
(22), Van Houten and McCullough (23), Moolenaar
et al.(24) and Fuchs and Seeberg (36), support the model
that suggest UvrA locates the damaged region and attracts
UvrB binding. After UvrB binding, UvrA is released from
the damaged region (20,22–25). The reason for the dispar-
ate results from these laboratories that lead to two models
to account for UvrABC incision is unclear. One possibility
is due that the DNA lesions used as UvrABC substrates
and the method to assess Uvr–DNA lesion complex
formation by Grossman’s laboratory (28) are different
from Sancar (22), Van Houten and McCullough (23),
Moolenaar et al. (24) and Fuchs and Seeberg (36). Our
current results using MC–DNA adducts as UvrABC sub-
strate are consistent with Grossman and Yeung’s model
(28). There is evidence that DNA wraps around UvrB and
causes strand separation in the damaged region (37,38).
UvrC then joins the UvrB–DNA damage complex and
triggers strand incision (23–25,29). The role of strand sep-
aration for UvrB and UvrC incision is clear for
mono-DNA adduct lesions but is unclear for ICL
lesions. The dual incision on the outward furan-linked
strand containing an ICL dT-psoralen-dT lesion suggests
that helix kinking of the DNA wrapped around UvrB
plays a crucial role. If this is the case, then it is expected
that the UvrABC incision of an ICL dG-MC-dG lesion
will be different since this type of lesion does not cause
DNA kinking or bending and either DNA strand can
wrap around UvrB molecules. The signal for UvrA
binding at this ICL lesion probably comes from the
changing helix ﬂuidity caused by this type of lesion (39).
Our gel retardation results indicate that UvrA remains
bound to the MC-modiﬁed DNA fragments after
addition of UvrB and UvrC proteins; this differs from
the results of van Houten et al. (11,12), who showed
that upon UvrB binding UvrA was released from the
complex. In addition and in contrast to their results, we
did not observe a signiﬁcant amount of UvrA,
(UvrA+UvrB) or (UvrA+UvrB+UvrC) binding on
control DNA, indicating that the Uvr-MC modiﬁed
DNA complexes we observed are productive complexes
that eventually lead to UvrABC incisions.
It appears that the recognition and binding of the ICL
dG-MC-dG site by Uvr proteins do not follow a strict
sequence; if they did, a single type of UvrABC excision
would be observed, as we found for interaction of
UvrABC with MC-mono-dG adducts. Instead, we
observed three
32P-labeled fragments resulting from
UvrABC incision of an ICL dG-MC-dG adduct. The
possible models to account for these incisions are many.
However, the gel retardation results in Figure 5A show
that the UvrA-dG-MC-dG complex band moves more
slowly than the UvrA-MC-mono-dG complex band.
These results suggest that more than 1 dimerized UvrA
binds at ICL dG-MC-dG–adducted DNA, assuming
that 1 dimerized UvrA binds at UvrA-MC-mono-dG–
adducted DNA. We propose that two dimerized UvrA
proteins bind at each strand of an ICL dG-MC-dG-
adducted DNA with the same polarity relative to the
lesion. These two dimerized UvrA–DNA complexes
can attract two sets of UvrB and UvrC, and three types
of incision could then be triggered: (i) dual 50 and 30
incisions on both strands (type 3); (ii) dual incisions
on 1 strand and 30 single incision on the other strand
(type 2); and (iii) a single 50 incision on 1 strand and
a single 30 incision on the other (type 1), as depicted
in Figure 4. Although, in general, UvrABC makes dual
incisions 50 and 30 to bulky DNA damage, uncoupled
incision 50 to or 30 to DNA damage has also been
observed (40,41).
Our results suggest that the type 1 and type 3 incisions
for ICL dG-MC-dG are the most common UvrABC
repair mechanisms for ICL lesions, which result in the
generation of either 1 or 2 DSB, respectively. A signiﬁcant
fraction of UvrABC repair is through type 2 incisions,
which also generate 1 DSB. It is unclear what factors
determine what type of incision occurs. Since we only
have observed these three types of incision bands and
not intermediate bands, we suggest that once the Uvr
protein–ICL-dG-MC-dG complexes are formed they are
not interchangeable, and once a particular form of the
complex is formed at the ICL lesion it precludes formation
of other forms of the complex.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
We thank Drs. Michael Patrick and Yen-Yee Nydam for
critical review of this manuscript. We thank Yong Jiang
(University of California, Riverside) for MS analyses.
FUNDING
The National Institutes of Health (CA114541, ES014641,
CA99007 and ES00260); National Institute of
Environmental Health (ES09127 and ES013324);
National Cancer Institute (CA101864). Funding for
open access charge: National Institutes of Health
(CA114541 and ES00260).
Nucleic Acids Research, 2010,Vol.38, No. 20 6983Conﬂict of interest statement. None declared.
REFERENCES
1. Kusenda,Z., Kerger,J., Awada,A., Geurs,F., Van Vreckem,A.,
Habboubi,N. and Piccart,M.J. (1997) Mitomycin C and
vinblastine in combination with amifostine in metastatic breast
cancer. A feasibility study of the EORTC–Investigational Drug
Branch for Breast Cancer (IDBBC). Support Care Cancer, 5,
414–416.
2. Lenaz,L. (1985) Mitomycin C in advanced breast cancer. Cancer
Treat. Rev., 12, 235–249.
3. Bolenz,C., Cao,Y., Arancibia,M.F., Trojan,L., Alken,P. and
Michel,M.S. (2006) Intravesical mitomycin C for superﬁcial
transitional cell carcinoma. Expert Rev. Anticancer Ther., 6,
1273–1282.
4. Snegovoy,A., Manzuk,L. and Artamonova,E. (2008) Mitomycin
plus capecitabine in metastatic breast cancer. 2008 Breast Cancer
Symposium, General Poster Session E, Abstract No: 264.
5. Bizanek,R., McGuinness,B.F., Nakanishi,K. and Tomasz,M.
(1992) Isolation and structure of an intrastrand cross-link adduct
of mitomycin C and DNA. Biochemistry, 31, 3084–3091.
6. Dronkert,M.L. and Kanaar,R. (2001) Repair of DNA interstrand
cross-links. Mutat. Res., 486, 217–247.
7. Iyer,V.N. and Szybalski,W. (1964) Mitomycins and porﬁromycin:
chemical mechanism of activation and cross-linking of DNA.
Science, 145, 55–58.
8. Tomasz,M. and Palom,Y. (1997) The mitomycin bioreductive
antitumor agents: cross-linking and alkylation of DNA as the
molecular basis of their activity. Pharmacol. Ther., 76, 73–87.
9. Tang,M.-s. (1996) Mapping and quantiﬁcation of bulky
chemical-induced DNA damage using UvrABC nucleases.
Technol. Detect. DNA Damage Mutat., Chapter 11, 139–152.
10. Li,V.S., Reed,M., Zheng,Y., Kohn,H. and Tang,M.-s. (2000) C5
cytosine methylation at CpG sites enhances sequence selectivity of
mitomycin C-DNA bonding. Biochemistry, 39, 2612–2618.
11. Van Houten,B., Gamper,H., Holbrook,S.R., Hearst,J.E. and
Sancar,A. (1986a) Action mechanism of ABC excision nuclease
on a DNA substrate containing a psoralen crosslink at a deﬁned
position. Proc. Natl Acad. Sci. USA, 83, 8077–8081.
12. Van Houten,B., Gamper,H., Hearst,J.E. and Sancar,A. (1986b)
Construction of DNA substrates modiﬁed with psoralen at a
unique site and study of the action mechanism of ABC
excinuclease on these uniformly modiﬁed substrates.
J. Biol. Chem., 261, 14135–14141.
13. Ramaswamy,M. and Yeung,A.T. (1994) Sequence-speciﬁc
interactions of UvrABC endonuclease with psoralen interstrand
cross-links. J. Biol. Chem., 269, 485–492.
14. Sladek,F.M., Munn,M.M., Rupp,W.D. and Howard-Flanders,P.
(1989a) In vitro repair of psoralen-DNA cross-links by RecA,
UvrABC, and the 50-exonuclease of DNA polymerase I.
J. Biol. Chem., 264, 6755–6765.
15. Sladek,F.M., Melian,A. and Howard-Flanders,P. (1989b) Incision
by UvrABC excinuclease is a step in the path to mutagenesis by
psoralen crosslinks in Escherichia coli. Proc. Natl Acad. Sci.
USA, 86, 3982–3986.
16. Rink,S.M., Lipman,R., Alley,S.C., Hopkins,P.B. and Tomasz,M.
(1996) Bending of DNA by the mitomycin C-induced, GpG
intrastrand cross-link. Chem. Res. Toxicol., 9, 382–389.
17. Pearlman,D.A., Holbrook,S.R., Pirkle,D.H. and Kim,S.H. (1985)
Molecular models for DNA damaged by photoreaction. Science,
227, 1304–1308.
18. Wang,Y. (2003) Structure elucidation of DNA interstrand
cross-link by a combination of nuclease P1 digestion with mass
spectrometry. Anal. Chem., 75, 6306–6313.
19. Borowy-Borowski,H., Lipman,R., Chowdary,D. and Tomasz,M.
(1990) Duplex oligodeoxyribonucleotides cross-linked by
mitomycin C at a single site: synthesis, properties, and cross-link
reversibility. Biochemistry, 29, 2992–2999.
20. Delagoutte,E., Bertrand-Burggraf,E., Lambert,I.B. and Fuchs,R.P.
(1996) Binding and incision activities of UvrABC excinuclease on
slipped DNA intermediates that generate frameshift mutations.
J. Mol. Biol., 257, 970–976.
21. Kohn,H., Li,V.S. and Tang,M.-S. (1992) Recognition of
mitomycin C-DNA monoadducts by UVRABC nuclease. J. Am.
Chem. Soc., 114, 5501–5509.
22. Sancar,A. (1996) DNA excision repair. Annu. Rev. Biochem., 65,
43–81.
23. Van Houten,B. and McCullough,A. (1994) Nucleotide excision
repair in E. coli. Ann. NY Acad. Sci., 726, 236–251.
24. Moolenaar,G.F., Herron,M.F., Monaco,V., van der Marel,G.A.,
van Boom,J.H., Visse,R. and Goosen,N. (2000) The role of ATP
binding and hydrolysis by UvrB during nucleotide excision repair.
J. Biol. Chem., 275, 8044–8050.
25. Truglio,J.J., Croteau,D.L., Van Houten,B. and Kisker,C. (2006)
Prokaryotic nucleotide excision repair: the UvrABC system.
Chem. Rev., 106, 233–252.
26. Gordienko,I. and Rupp,W.D. (1998) A speciﬁc 3’ exonuclease
activity of UvrABC. EMBO J., 17, 626–633.
27. Caron,P.R. and Grossman,L. (1988) Incision of damaged versus
nondamaged DNA by the Escherichia coli UvrABC proteins.
Nucleic Acids Res., 16, 7855–7865.
28. Grossman,L. and Yeung,A.T. (1990) The UvrABC endonuclease
system of Escherichia coli–a view from Baltimore. Mutat. Res.,
236, 213–221.
29. Friedberg,E.C., Walker,G.C. and Siede,W. (1995) Nucleotide
excision repair in prokaryotes. DNA Repair Mutagen., Chapter 5,
191–225.
30. Batty,D.P. and Wood,R.D. (2000) Damage recognition in
nucleotide excision repair of DNA. Gene, 241, 193–204.
31. Petit,C. and Sancar,A. (1999) Nucleotide excision repair: from
E. coli to man. Biochimie, 81, 15–25.
32. Verweij,J. and Pinedo,H.M. (1990) Mitomycin C: mechanism of
action, usefulness and limitations. Anticancer Drugs, 1, 5–13.
33. Piette,J. and Hearst,J. (1985) Sites of termination of in vitro
DNA synthesis on psoralen phototreated single-stranded
templates. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med., 48,
381–388.
34. Peng,X., Ghosh,A.K., Van Houten,B. and Greenberg,M.M.
(2010) Nucleotide excision repair of a DNA interstrand cross-link
produces single- and double-strand breaks. Biochemistry, 49,
11–19.
35. Sczepanski,J.T., Jacobs,A.C., Van Houten,B. and
Greenberg,M.M. (2009) Double-strand break formation during
nucleotide excision repair of a DNA interstrand cross-link.
Biochemistry, 48, 7565–7567.
36. Fuchs,R.P. and Seeberg,E. (1984) pBR322 plasmid DNA modiﬁed
with 2-acetylaminoﬂuorene derivatives: transforming activity and
in vitro strand cleavage by the Escherichia coli uvrABC
endonuclease. EMBO J., 3, 757–760.
37. Verhoeven,E.E., Wyman,C., Moolenaar,G.F., Hoeijmakers,J.H.
and Goosen,N. (2001) Architecture of nucleotide excision repair
complexes: DNA is wrapped by UvrB before and after damage
recognition. EMBO J., 20, 601–611.
38. Wang,H., Lu,M., Tang,M.-s., Van Houten,B., Ross,J.B.,
Weinfeld,M. and Le,X.C. (2009) DNA wrapping is required for
DNA damage recognition in the Escherichia coli DNA nucleotide
excision repair pathway. Proc. Natl Acad. Sci. USA, 106,
12849–12854.
39. Walter,R.B., Pierce,J., Case,R. and Tang,M.-s. (1988) Recognition
of the DNA helix stabilizing anthramycin-N2 guanine adduct by
UVRABC nuclease. J. Mol. Biol., 203, 939–947.
40. Tang,M.-s., Lee,C.S., Doisy,R., Ross,L., Needham-
VanDevanter,D.R. and Hurley,L.H. (1988) Recognition and
repair of the CC-1065-(N3-adenine)-DNA adduct by the
UVRABC nucleases. Biochemistry, 27, 893–901.
41. Nazimiec,M., Lee,C.S., Tang,Y.L., Ye,X., Case,R. and Tang,M.-s.
(2001) Sequence-dependent interactions of two forms of UvrC
with DNA helix-stabilizing CC-1065-N3-adenine adducts.
Biochemistry, 40, 11073–11081.
42. Maxam,A.M. (1980) Sequencing the DNA of recombinant
chromosomes. Fed. Proc., 39, 2830–2836.
6984 Nucleic Acids Research, 2010,Vol.38, No. 20